Quarterly report pursuant to sections 13 or 15(d)

COMMON STOCK PURCHASE WARRANTS AND OPTIONS

v2.4.0.8
COMMON STOCK PURCHASE WARRANTS AND OPTIONS
3 Months Ended
Mar. 31, 2014
COMMON STOCK PURCHASE WARRANTS AND OPTIONS [Abstract]  
COMMON STOCK PURCHASE WARRANTS AND OPTIONS

NOTE 13 - COMMON STOCK PURCHASE WARRANTS AND OPTIONS


Warrants


Following is a summary of activity for warrants to purchase Class A common stock for the three months ending March 31, 2014.


                 

 

 

March 31, 2014

 

  

 

Shares

 

 

Weighted

Avg

Exercise

Price

 

Outstanding at beginning of period

 

 

29,859,375

 

 

$

0.031

 

Granted

 

 

6,874,688

 

 

$

0.012

 

Exercised

 

 

7,875,000

 

 

$

0.012

 

Outstanding at end of period

 

 

28,859,063

 

 

$

0.02

 

Exercisable at end of period

 

 

28,859,063

 

 

$

0.02

 


See Note 12 for discussion of warrant activity for the three months ended March 31, 2014.


On January 22, 2014, the Board of Directors approved the modification of warrants to purchase 3,750,000 and 4,125,000 shares of the Company's common stock by reducing the exercise price of each prior grant from $0.025 and $0.033 respectively, to $0.01 per share.  The Company revalued the warrants just prior to and after the modification and there was no material incremental increase in value.  The warrants were then exercised under the cashless exercise provisions (See Note 12).


Options


Following is a summary of stock option activity for the three months ending March 31, 2014.


                 

 

 

March 31, 2014

 

  

 

Shares

 

 

Weighted

Avg

Exercise

Price

 

Outstanding at beginning of period

 

 

1,000,000

 

 

$

0.030

 

Granted

 

 

3,150,000

 

 

$

0.02

 

Outstanding at end of period

 

 

4,150,000

 

 

$

0.02

 

Exercisable at end of period

 

 

2,000,000

 

 

$

0.02

 


The total unrecognized option expense to be recorded over the remaining 3 months is $21,870.


On January 1, 2014, the Company issued stock options to purchase 1,000,000 shares of Class A common stock with an exercise price of $0.02 and valued at $0.02 per option for a total of $20,000 to its CEO. The options vest June 30, 2014. The options were valued using the Black-Scholes model with a dividend rate of 0%, volatility of 294%, risk free interest rate of 0.76% and a term of 5 years. The expense in 2014 was $10,000.


On January 1, 2014, the Company issued stock options to purchase 1,000,000 shares of Class A common stock with an exercise price of $0.02 and valued at $0.02 per option for a total of $20,000 to its President and CFO. The options vest June 30, 2014. The options were valued using the Black-Scholes model with a dividend rate of 0%, volatility of 294%, risk free interest rate of 0.76% and a term of 5 years. The expense in 2014 was $10,000.


On January 22, 2014, the Company approved the issuance of 1,000,000 options to an independent financial consultant to act as an advisor to the Company with respect to international capital markets strategy. The consultant received no other cash or stock compensation and continues to work closely with the Company on matters directly pertaining to capitalization. The options have an exercise price of $0.018 per share, a five-year term, vesting immediately. The options were valued using the Black-Scholes model using a volatility of 294%, an expected term of 5 years and an interest rate of 0.76%. The options were valued at $18,000 and were immediately expensed.


On March 26, 2014, the Company issued stock options to purchase 150,000 shares of Class A common stock with an exercise price of $0.012 valued at $0.013 per option for a total of $1,900 to its independent director. The options vest June 30, 2014. The options were valued using the Black-Scholes model with a dividend rate of 0%, volatility of 294%, risk free interest rate of 0.76% and a term of 5 years. The expense in 2014 was not material.